uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted October 22, 2019

Company Marketing CBD for Use in Infants and Children Gets Strong Warning

On October 10, 2019, the FDA and FTC issued a joint warning letter to Rooted Apothecary LLC for "illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims" including that the products could treat teething pain and ear aches in infants, autism, attention-deficit/hyperactivity disorder (ADHD), as well as Parkinson's and Alzheimer's disease.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at